Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Postgraduate Medicine|August 12, 2009
Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistanceRobert P RappPharmacotherapy|March 3, 2004
Changing strategies for the management of invasive fungal infectionsRobert P RappPharmacotherapy|April 11, 2012
Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concernsRobert P Rapp, Carl UrbanOrthopedics|November 22, 2005
Why is the microbiology lab calling about an extended-spectrum beta-lactamase bacterium from a wound culture?Julie Ribes, Robert P RappOrthopedics|July 9, 2004
Methicillin-resistant staphylococcal infections: an important consideration for orthopedic surgeonsWael E Shams, Robert P RappAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2008
Bugs versus drugs: addressing the pharmacist's challengeDavid S Burgess, Robert P RappNature|October 10, 2003
Growth of early continental crust by partial melting of eclogiteRobert P Rapp, Nobumichi Shimizu, Marc D NormanPharmacotherapy|January 17, 2002
The effect of an antimicrobial formulary change on hospital resistance patternsKerry M Empey, Robert P Rapp, Martin E EvansPharmacotherapy|June 28, 2007
Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazoleDavid J Feola, Beth A Garvy, Robert P Rapp, et al.Pharmacotherapy|March 16, 2005
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureusShellee A Grim, Robert P Rapp, Craig A Martin, et al.Pageof 2